No Detail Found!

Exploring the therapeutic mechanism of Zijin Ding in treating colorectal cancer based on network pharmacology and molecular docking

Author(s)
Shaozhuang Chen Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University,Xiamen,China
Yufu Lin Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University,Xiamen,China
Fangwei Chen Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University,Xiamen,China
Yabo Chen Department of General Practice, Zhongshan Hospital (Xiamen), Fudan University,Xiamen,China
Shan Ding Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University,Xiamen,China
Luming Wang Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University,Xiamen,China
Yun Shen Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University,Xiamen,China
Yanrong Ye Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University,Xiamen,China
Jia Liu Department of Integrated Traditional Chinese and Western Medicine, Zhongshan Hospital (Xiamen), Fudan University,Xiamen,China
Abstract
To predict the core components, targets, and pathways of Zijin Ding in treating colorectal cancer using network pharmacology and to explore its mechanism. Active ingredients and targets of Zijin Ding were retrieved from databases like TCMSP and Herb, and colorectal cancer-related targets were identified via GeneCards. Common targets were analyzed using Venn diagrams and String database, with Cytoscape for visualization. GO and KEGG analyses were performed using Metascape, and molecular docking was done with Auto Dock-Vina. Experimental validation was also included. We identified 20 components in Zijin Ding, with 228 overlapping targets related to cancer, including 20 core targets. These targets are involved in 1115 GO terms and 164 KEGG pathways. Key active ingredients like morin, alpha-estradiol, and beta-estradiol were predicted to interact with targets such as TP53, AKT1, IL6, CASP3, and BCL2. Molecular docking showed good binding activities of these ingredients with the targets. The chemical composition, including 4-gingerol, 6gingerol, and 6-shogaol, was clarified. Zijin Ding treats colorectal cancer through a "multiple components, multiple targets, multiple pathways" network, providing theoretical references for its pharmacological and clinical applications. The experimental data support the network pharmacology predictions and highlight Zijin Ding's potential in colorectal cancer treatment.
Publication Details
Page(s) 1029-1037
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Colon cancer, network pharmacology, Mechanism of action, Zijin Ding
References
Chen JJ,Men WQ,Cheng ZQ,Xu QH,Dai TT .2013 .Clinical significance of combined detection of serum IL6, CEA, and CA19-9 in patients with colorectal cancer. Chin. J. Imm., 29(12) : 1071-1073.
Chen X,Guan H,Liu XD,Xie DF,Wang Y,Ma T,Huang B,Zhou PK B .2018 .3 positively regulates the expression of cancer stem cell marker CD133 in HCT116 colon cancer cells. Oncol. Lctt, 16(1) : 131-138.
Chen X,Liang H,Song Q,Xu X,Cao D X .2018 .Insulin promotes progression of colon cancer by upregulation of ACAT1. Lipids Health Dis. , 17(1) : 122.
Dilixia S,Li F,Zhang WJ .2012 .The Relationship Between IL-17 Structure, Its signaling pathway and tumors. J. Nongken Med, 34(2) : 166-171.
Duan J,Zhang J,Sun J,Fang YL .2024 .The Mechanism of morin combined with celastrol induces apoptosis and inhibits the growth of lung cancer. Food Sci. Hum, : 1-14.
Grivennikov S,Karin E,Terzic J,Mucida D,Yu GY,Vallabhapurapu S,Scheller J,Rose-John S,Cheroutre H,Eckmann L,Karin M .2009 .IL-6 and Stat3 arc required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer cell, 15(2) : 103-113.
Hsin KY,Chosh S,Kitano H S .2013 .Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS, 8(12) : c83922.
Itoh N,Semba S,Ito M,Takeda H,Kawata S,Yamakawa M .2002 .Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer, 94(12) : 3127-34.
Jiang JK,Mo WG .2010 .Mutation of PIK3CA gene and expression of AKT1/2 protein in colorectal cancer tissues and their significance. Guangxi Med, 32(1) : 21-27.
Jing GC,Liu D,Liu YQ,Zhang MR .2020 .Nao-FuCong ameliorates diabetic cognitive dysfunction by inhibition of JNK/CHOP/Bcl2-mediated apoptosis in vivo and in vitro. Chin. J. Nat. Med, 18(09) : 704-713.
Knüpfer H and Preiss R .2010 .Serum interleukin-6 levels in colorectal cancer patients--a summary of published results. Int. J. Colorectal Dis, 25(2) : 135-10.
Laptenko O and Prives C .2006 .Transcriptional regulation by p53: Oneprotcin, many possibilities. Cell Death Differ., 1(6) : 951-961.
Li QR .2018 .Effects of 17β-estradiol on the synthesis, secretion, and receptor expression of PGE_2 and PGF_ (2α) in bovine endometrial tissue. Master's Thesis, : .
Lin QF,He FP,Xu X,Wu QS,Li DY,Ma ZZ,Guo YL,Tang S,Yin WD,Gong HT,Liu Y,Lin HX .2017 .Expression and clinical significance of AKT and PI3K genes in the feces of patients with colorectal cancer. Mod, 28(10) : 1771-1773.
Liu H,Wang X,Wang P,Wang YQ,Yi YY,Li X .2023 .Novel protein C6ORF120 promotes apoptosis through mitochondria-dependent Pathway in CD4 +T Lymphocytes. Biomed. Environ. Sci., 36(07) : 639-643.
Lu CC,Chu PY,Hsia SM,Wu CH,Tung YT,Yen GC .2017 .Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells. Int. J. Oncol., 50(2) : 736-744.
Nakayama M and Oshima M .2019 .Mutant p53 in colon cancer. J. Mol. Bio1, 11 : 267-276.
Qin Y,Chen H,Liu P,Zhang C,Yang J,Gui L,He X,Zhou L,Zhou S,Jiang S,Jiang H,Shi Y H .2022 .Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP. Cancer Biol. Med, 19(06) : 893-909.
Shi JJ,Liu CQ .2008 .Research progress on the correlation between interleukin-6 and tumors. Chem. Life, 20(1) : 12-11.
Xu L,Zhang XJ,Zhang RZ,Yao QH .2020 .Study on the mechanism of curcumin reversing drug resistance in colon cancer HCT-116 SFU cells. Zhejiang J. Int. Trad. Chin. West. Med, 30(6) : 454-457.
Yang B,Yang Z,Tang DT,Long FX,Luo L,Li J,Guo B,Wang JH,Huang WQ .2016 .Prevention and treatment roles of traditional Chinese medicine in colorectal cancer. Mod. J. Int. Tradi. Chin. West. Med, 25(21) : 2389-2391.
Yang HG .2015 .External application of Zijin Ding combined with intracavitary injection of lentinan in the treatment of cancerous pleural effusion and ascites: A report of 28 cases. Guangming J Chin. Med, 30(04) : 772-774.
Zhang JD,Yin RF,Chen Q,Yang S .2021 .Investigation of the potential mechanism of danggui buxue decoction in treating atherosclerosis based on network pharmacology and molecular docking. World Sci. Tech. Mod. Trad. Chin. Med, 23 : 1076-1085.
Zhao X,Gu Y,Zhang L,Du WT .2024 .Exploration of the mechanism of ruanmai decoction in treating atherosclerosis based on the YWHAZ/p38MAPK/ CASP3 Signaling Pathway. Chin. Pharmacol. Bull., 40(03) : 573-581.
Zhao Y,Yuan LR,Zhang WH,Yu YQ .1999 .Treatment of leukemia patients with phlebitis using anisodamine, Zijin Ding and vitamin B (12). Heilongjiang Med. , 03 : 67-68.
0

Citations

0

Downloads

103

Views